Zhi-Jun Pei (Zhijun Pei)

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 12

Top Topics

Vascular Endothelial Growth Factor

Staphylococcus Aureus

Top Venues

Scientific reports

Journal of cellular and molecular medicine

Journal of translational medicine

European journal of nuclear medicine and molecular imaging

This page only lists publications with an associated author ORCID identifier.

Publications

Xu-Sheng Liu, Yu Zhang, Zi-Yue Liu, Yan Gao, Ling-Ling Yuan, Dao-Bing Zeng, Fan Tan, Hua-Bing Wan, Zhi-Jun Pei
METTL3 as a novel diagnosis and treatment biomarker and its association with glycolysis, cuproptosis and ceRNA in oesophageal carcinoma. Journal of cellular and molecular medicine 28 (6) (2024)
Xu-Sheng Liu, Yu Zhang, Zi-Yue Liu, Yan Gao, Ling-Ling Yuan, Dao-Bing Zeng, Fan Tan, Hua-Bing Wan, Zhi-Jun Pei
METTL3 as a novel diagnosis and treatment biomarker and its association with glycolysis, cuproptosis and ceRNA in oesophageal carcinoma. Journal of cellular and molecular medicine 28 (6) (2024)
Xu-Sheng Liu, Yu-Xuan Chen, Hua-Bing Wan, Ya-Lan Wang, Yang-Yang Wang, Yan Gao, Li-Bing Wu, Zhi-Jun Pei
TRIP6 a potential diagnostic marker for colorectal cancer with glycolysis and immune infiltration association. Scientific reports 14 (1) (2024)
Xu-Sheng Liu, Yu-Xuan Chen, Hua-Bing Wan, Ya-Lan Wang, Yang-Yang Wang, Yan Gao, Li-Bing Wu, Zhi-Jun Pei
TRIP6 a potential diagnostic marker for colorectal cancer with glycolysis and immune infiltration association. Scientific reports 14 (1) (2024)
Xu-Sheng Liu, Yu Zhang, Zi-Yue Liu, Yan Gao, Ling-Ling Yuan, Dao-Bing Zeng, Fan Tan, Hua-Bing Wan, Zhi-Jun Pei
METTL3 as a novel diagnosis and treatment biomarker and its association with glycolysis, cuproptosis and ceRNA in oesophageal carcinoma. Journal of cellular and molecular medicine 28 (6) (2024)
Xu-Sheng Liu, Yu-Xuan Chen, Hua-Bing Wan, Ya-Lan Wang, Yang-Yang Wang, Yan Gao, Li-Bing Wu, Zhi-Jun Pei
TRIP6 a potential diagnostic marker for colorectal cancer with glycolysis and immune infiltration association. Scientific reports 14 (1) (2024)
Xu-Sheng Liu, Yu-Xuan Chen, Hua-Bing Wan, Ya-Lan Wang, Yang-Yang Wang, Yan Gao, Li-Bing Wu, Zhi-Jun Pei
TRIP6 a potential diagnostic marker for colorectal cancer with glycolysis and immune infiltration association. Scientific reports 14 (1) (2024)
Xu-Sheng Liu, Yu-Xuan Chen, Hua-Bing Wan, Ya-Lan Wang, Yang-Yang Wang, Yan Gao, Li-Bing Wu, Zhi-Jun Pei
TRIP6 a potential diagnostic marker for colorectal cancer with glycolysis and immune infiltration association. Scientific reports 14 (1) (2024)
Xu-Sheng Liu, Ling-Ling Yuan, Yan Gao, Xing Ming, Yao-Hua Zhang, Yu Zhang, Zi-Yue Liu, Yi Yang, Zhi-Jun Pei
DARS2 overexpression is associated with PET/CT metabolic parameters and affects glycolytic activity in lung adenocarcinoma. Journal of translational medicine 21 (1) (2023)
Xiao-Yu Liu, Yan Gao, Xue-Yan Kui, Xu-Sheng Liu, Yao-Hua Zhang, Yu Zhang, Chang-Bin Ke, Zhi-Jun Pei
High expression of HNRNPR in ESCA combined with 18 F-FDG PET/CT metabolic parameters are novel biomarkers for preoperative diagnosis of ESCA. Journal of translational medicine 20 (1) (2022)
Yan Gao, Lingling Yuan, Jing Zeng, Fuyan Li, Xiaohui Li, Fan Tan, Xusheng Liu, Huabing Wan, Xueyan Kui, Xiaoyu Liu, Changbin Ke, Zhi-Jun Pei
eIF6 is potential diagnostic and prognostic biomarker that associated with 18 F-FDG PET/CT features and immune signatures in esophageal carcinoma. Journal of translational medicine 20 (1) (2022)
Lu-Meng Zhou, Ling-Ling Yuan, Yan Gao, Xu-Sheng Liu, Qin Dai, Jian-Wei Yang, Zhi-Jun Pei
Nucleophosmin 1 overexpression correlates with 18F-FDG PET/CT metabolic parameters and improves diagnostic accuracy in patients with lung adenocarcinoma. European journal of nuclear medicine and molecular imaging 48 (3) (2020)